It works by simultaneously activating three incretin-related receptors: the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor
Tirzepatide produces about 20-22% weight loss
TB-4 (full-length thymosin 4, 43 aa) Moves repair cells (fibroblasts) into position and biases healing toward functional tissue rather than rope-like scarring. KPV Pre-empts the inflammation switch before it activates, so reactive skin doesnt drown the rebuilding signals
However, these tests were done on bacteria in a petri dish and not on real skin, so we can't say for certain it works the same in a formulation on a real face
Brighten: So would you say everybody with thyroid disease should consider these medications or is everybody a candidate
In this photo illustration, the injectable weight-loss medication Wegovy is available at a Chicago pharmacy last year